Literature DB >> 9536327

Ipriflavone for the treatment of osteoporosis.

Y K Choi1, I K Han, H K Yoon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9536327     DOI: 10.1007/bf03194367

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  17 in total

1.  Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone.

Authors:  D Agnusdei; C Gennari; L Bufalino
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

2.  Metabolic and bone effects after administration of ipriflavone and salmon calcitonin in postmenopausal osteoporosis.

Authors:  M Cecchettin; S Bellometti; G Cremonesi; L P Solimeno; G Torri
Journal:  Biomed Pharmacother       Date:  1995       Impact factor: 6.529

3.  Ipriflavone improves bone density and biomechanical properties of adult male rat bones.

Authors:  R Civitelli; S H Abbasi-Jarhomi; L R Halstead; A Dimarogonas
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

4.  Characterization of cells isolated and cultured from human bone.

Authors:  J E Wergedal; D J Baylink
Journal:  Proc Soc Exp Biol Med       Date:  1984-05

5.  Mortality and morbidity after hip fractures.

Authors:  G S Keene; M J Parker; G A Pryor
Journal:  BMJ       Date:  1993-11-13

6.  Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group.

Authors:  S R Cummings; D M Black; M C Nevitt; W Browner; J Cauley; K Ensrud; H K Genant; L Palermo; J Scott; T M Vogt
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

7.  Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis.

Authors:  D Agnusdei; S Adami; R Cervetti; G Crepaldi; O Di Munno; L Fantasia; G C Isaia; G Letizia; S Ortolani; M Passeri
Journal:  Bone Miner       Date:  1992-10

8.  Effects of ipriflavone and its metabolites on human articular chondrocytes cultivated in clusters.

Authors:  C T Bassleer; P P Franchimont; Y E Henrotin; N M Franchimont; V G Geenen; J Y Reginster
Journal:  Osteoarthritis Cartilage       Date:  1996-03       Impact factor: 6.576

Review 9.  Osteoporosis.

Authors:  J P Devogelaer; C Nagant de Deuxchaisnes
Journal:  Br J Rheumatol       Date:  1993-06

10.  Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites.

Authors:  S L Cheng; S F Zhang; T L Nelson; P M Warlow; R Civitelli
Journal:  Calcif Tissue Int       Date:  1994-11       Impact factor: 4.333

View more
  1 in total

1.  Osteoporosis Update 1997. Symposium proceedings. Osaka, Japan, 13-16 November 1997.

Authors: 
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.